left-caret

NEWS

Paul Hastings Advised TD Securities in Forte Biosciences’ Oversubscribed Private Placement

November 20, 2024

Paul Hastings LLP advised TD Securities (USA) LLC as lead placement agent in connection with Forte Biosciences, Inc.’s (NASDAQ: FBRX) oversubscribed $53 million PIPE financing.

The Paul Hastings team included Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group Seo Salimi and partner Will Magioncalda.

More details can be found here.

About Paul Hastings

With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment, and real estate, Paul Hastings is a premier law firm providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers, and corporations.

Practice Areas

Life Sciences and Healthcare

Securities and Capital Markets


SIGN UP FOR NEWS INSIGHTS

MEDIA CONTACTS

Corporate, Litigation, Real Estate, Intellectual Property, Life Sciences, and Employment

Becca Hatton

Paris

Katy Foster

Europe

Miranda Ward

Submission Requests

Firmwide Inquiries

Elliott Frieder